PRA Health Sciences, Inc.
PRAHDelisted Jul 1, 2021- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001613859
PRA Health Sciences, Inc. was delisted on Jul 1, 2021; its insiders filed their last Form 4 on Jul 1, 2021; 317 institutions reported holding it in 13F filings for Q2 2021, worth $10.1B in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in PRA Health Sciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
PRAH is no longer listed, and 13F filings after Q2 2021 list far fewer holders. See Q2 2021
- Institutional holders
- 0
- −1 vs. Q3 2021
- Shares held
- 0
- −11.7K (−100.0%) vs. Q3 2021
- Total value
- $0
- −$1.93M (−100.0%) vs. Q3 2021
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRAH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 1 | $1.93M |
| Q2 2021 | 317 | $10.1B |
| Q1 2021 | 324 | $9.55B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding PRA Health Sciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Brinker Capital Investments, LLC | 0 | $0 | 0.00% | −11,671−100.0% | Sold out |